| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC65014 | m-PEG8-CH2COOH Featured | m-PEG8-CH2COOH is a PEG--based PROTAC linker can be used in the synthesis of PROTACs. |
|
| DC65015 | m-PEG10-CH2COOH Featured | m-PEG10-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
| DC65016 | AGPS-IN-2i Featured | AGPS-IN-2i is a novel inhibitor of alkylglyceronephosphate synthase (agps), specifically impairing epithelial to mesenchymal transition (emt) by modulating e-cadherin, snail and mmp2 expression levels. |
|
| DC65017 | β-Glucuronidase-IN-1 Featured | β-Glucuronidase-IN-1 is a potent, selective, uncompetitive, and orally active E. coli bacterial β-glucuronidase inhibitor, exhibiting an IC50 and a Ki of 283 nM and 164 nM, respectively. |
|
| DC65018 | 2-Formyl-3-hydroxybenzoic acid Featured |
|
|
| DC65019 | Isolithocholic acid (β-Lithocholic acid) Featured | Isolithocholic acid (β-Lithocholic acid) is an isomer of Lithocholic acid. Isolithocholic acid, a bile acid, is formed by microbial metabolism of Lithocholic acid or Lithocholic acid 3α-sulfate. |
|
| DC65020 | (S)-2-fluoropropionic acid Featured |
.png)
|
|
| DC65021 | H2-Gamendazole Featured | H2-Gamendazole is a derivative of Lonidamine that reduces cyst formation in polycystic kidney disease and is used in autosomal dominant polycystic kidney disease research. |
|
| DC65022 | 1,2,5-Oxadithiolane, 2,2,5,5-tetraoxide Featured |
|
|
| DC65023 | ACE-083 Featured | ACE083 is a Locally acting muscle-promoting agent |
|
| DC65024 | CPI-455 HCl Featured |
|
|
| DC65025 | Fluoromethanesulfonyl chloride Featured |
|
|
| DC65026 | 1H-Phenalene Featured |
|
|
| DC65027 | 9H-Purin-6-amine, 2-chloro-N-[(4,6-dimethyl-3-pyridinyl)methyl]-9-(1-methylethyl)- Featured |
|
|
| DC65028 | 4-(((1r,4r)-4-aminocyclohexyl)oxy)-2-chlorobenzonitrile hydrochloride Featured |
|
|
| DC65029 | Vactosertib HCl Featured | Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a small-molecule ATP-competitive inhibitor of TGFβRI (ALK5) with an IC50 of 12.9 nM. |
|
| DC65030 | Benzoic acid, 2-(2,2,2-trifluoro-1-methylethyl)hydrazide Featured |
|
|
| DC65031 | 1-(1,1,1-trifluoropropan-2-yl)hydrazine Featured |
|
|
| DC65032 | (1S)-2,2,2-trifluoro-1-methylethyl]hrazine hydrocydhloride Featured |
|
|
| DC65033 | Benzoic acid, 2-[(1S)-2,2,2-trifluoro-1-methylethyl]hydrazide Featured |
|
|
| DC65034 | 7-Nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-indole Featured |
.png)
|
|
| DC65035 | 1H-Indole, 3-(2-chloro-5-fluoro-4-pyrimidinyl)-1-[(4-methylphenyl)sulfonyl]-7-nitro- Featured |
|
|
| DC65036 | sodium 2-(4-methylpiperazin-1-yl)thiazole-5-carboxylate Featured |
|
|
| DC65037 | 2-AMINO-6-METHYL-N-O-TOLYLBENZAMIDE Featured |
|
|
| DC65038 | 5-Pyrimidinecarbonitrile,6-[2-(dimethylamino)ethenyl]-1,4-dihydro-4-oxo-1-phenyl- Featured |
|
|
| DC65039 | Benzo[b][1,6]naphthyridine-4-carbonitrile, 3-chloro- Featured |
|
|
| DC65040 | CAL-130 Racemate Featured | CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor. |
|
| DC65041 | Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate Featured |
|
|
| DC65042 | Methyl 3-(methoxymethyl)-1H-pyrazole-4-carboxylate Featured |
|
|
| DC65043 | [1(2H),2'-Bipyridin]-2-one, 3-amino- Featured |
|
